SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOctopus Ap Regulatory News (OAP3)

Share Price Information for Octopus Ap (OAP3)

Share Price is delayed by 15 minutes
Get Live Data
45.70    0.00 (0.00%)
Bid:
44.20
Ask:
47.20
Spread: 3.00 (6.787%)
Market Cap: £542.23m
OAP3 Live PriceLast checked at - London Stock Exchange

Intraday Octopus Ap Share Chart

Board Changes

15 Sep 2025 14:00

Board Changes

Octopus Apollo VCT plc

Board Changes

Octopus Apollo VCT plc (‘the Company’) is delighted to announce the appointments of Lindsay Dodsworth and Graeme Gunn as independent non-executive directors of the Company with effect from 15 September 2025.

Lindsay is an experienced non-executive director and a charity trustee. A former partner at EY and non-executive director of Mobeus Income & Growth 4 VCT, Lindsay is currently a non-executive director on the Boards of the Franklin Global Trust, Elveden Farms Ltd, Chair of Governors of St. John’s College School in Cambridge and a Trustee on the Boards of Goodenough College and the Royal Philharmonic Orchestra. Lindsay was for 21 years the Director of a Family Office which had a strong focus on venture and growth capital. Lindsay has an MA from Cambridge University and qualified as a chartered accountant at what is now part of PWC.

Graeme was a founding Partner of SL Capital Partners, a private markets investment firm, a joint venture with what is now Aberdeen Investments, focused on venture capital, private equity, infrastructure and secondary transactions. Since 2019 he has been a Director at 3 Bridges Capital, an M&A advisory business. Graeme is the Chairman of the TravelTech business Maison Sport and is also a non-executive director of Cypress Creek Private Strategies, a US based investment fund focused on private equity and real assets. Graeme is a Chartered Accountant, qualifying with what is now a part of PWC and holds a MEng degree from Edinburgh University.

Lindsay and Graeme will become members of the Audit & Risk Committee, Management Engagement Committee and Nomination & Remuneration Committee of the Company, with effect from the date of their appointment. Neither Lindsay nor Graeme currently have any interest in the ordinary shares of the Company.

There is no additional information required to be disclosed pursuant to UKLR 6.4.8R in relation to the appointments.

Furthermore, the Company announces that Claire Finn has resigned from the Board. Claire will step down in October 2025 following the completion of the half year results process.

 Murray Steele, Chair of Octopus Apollo VCT plc said:

“We are delighted to welcome Lindsay and Graeme and know that they will make a great contribution to the Board. We look forward to benefitting from their wealth of experience. I would also like to thank Claire on behalf of the Board and shareholders for her contribution to Apollo since her appointment to the Board in September 2021.”

For further information please contact:

Rachel Peat Octopus Company Secretarial Services Limited Tel: +44 (0)80 0316 2067

LEI: 213800Y3XEIQ18DP3O53

Date   Source Headline
31st Dec 20213:00 pmGNWTotal voting rights
23rd Dec 20215:24 pmGNWPURCHASE OF OWN SECURITIES AND TOTAL VOTING RIGHTS
21st Dec 20214:09 pmGNWNet Asset Value
8th Dec 20217:00 amGNWPublication of Circular  
30th Nov 20214:59 pmGNWTotal voting rights and capital
29th Nov 20214:43 pmGNWTransaction in Own Shares and Total Voting Rights
24th Nov 202112:17 pmGNWDirector Declaration
12th Nov 20215:50 pmGNWDirector/PDMR Shareholding
12th Nov 20215:49 pmGNWIssue of Equity and Total Voting Rights
12th Nov 20215:47 pmGNWOffer for Subscription – Over Allotment Facility
10th Nov 20214:32 pmGNWRESULTS OF GENERAL MEETING
1st Nov 20215:44 pmGNWTotal Voting Rights and Capital
29th Oct 20216:00 pmGNWDirector Declaration
26th Oct 20211:59 pmGNWClose of Offer to new applications
21st Oct 20215:22 pmGNWPurchase of Own Securities and Total Voting Rights
22nd Sep 202112:26 pmGNWAmendment to an Investment Management Agreement
21st Sep 20212:35 pmGNWDirector Appointment
23rd Jul 20215:45 pmGNWDirector/PDMR Shareholding
23rd Jul 20215:41 pmGNWIssue of Equity and Total Voting Rights
22nd Jul 20215:32 pmGNWPurchase of Own Securities and Total Voting Rights
22nd Jul 20215:31 pmGNWIntention to Fundraise
5th Jul 20217:10 amGNWIssue of Equity and Total Voting Rights
5th Jul 20217:05 amGNWIssue of Equity and Total Voting Rights
5th Jul 20217:00 amGNWIssue of Equity and Total Voting Rights
30th Jun 20215:58 pmGNWTransaction in Own Shares
30th Jun 20212:20 pmGNWResult of AGM
25th Jun 20215:29 pmGNWResignation of a Director
14th Jun 20212:29 pmGNWClose of Offer
1st Jun 20215:32 pmGNWPurchase of Own Securities and Total Voting Rights
14th May 20217:00 amGNWAnnual Financial Report
27th Apr 20215:54 pmGNWTransaction in Own Shares and Total Voting Rights
12th Apr 20215:48 pmGNWIssue of Equity and Total Voting Rights
1st Apr 20215:30 pmGNWDirector/PDMR Shareholding
1st Apr 20214:50 pmGNWIssue of Equity and Total Voting Rights
29th Mar 20213:52 pmGNWDirector/PDMR Shareholding
29th Mar 20217:00 amGNWIssue of Equity and Total Voting Rights
19th Mar 20214:51 pmGNWTransaction in Own Shares and Total Voting Rights
19th Mar 20212:45 pmGNWIssue of supplementary prospectus
12th Mar 202110:00 amGNWNet Asset Value(s)
3rd Mar 202112:34 pmGNWProposed Increase in Size of Offer for Subscription
17th Feb 20212:00 pmGNWOffer for Subscription - Over Allotment Facility
20th Jan 20215:34 pmGNWTransaction in Own Shares and Total Voting Rights
18th Jan 202111:04 amGNWDirector/PDMR Shareholding
15th Jan 202112:06 pmGNWIssue of Equity and Total Voting Rights
21st Dec 20209:30 amGNWDirector/PDMR Shareholding
18th Dec 20203:00 pmGNWIssue of Equity and Total Voting Rights
16th Dec 20204:50 pmGNWTransaction in Own Shares and Total Voting Rights
14th Dec 20206:30 pmGNWNet Asset Value(s)
26th Nov 20205:20 pmGNWTransaction in Own Shares and Total Voting Rights
26th Nov 202010:00 amGNWDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.